Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Rosemery Membreno"'
Autor:
Brian M. Zeglis, Jason S. Lewis, Pat B. Zanzonico, Wolfgang W. Scholz, Sean Carlin, Kristen M. Cunanan, Dalya Abdel-Atti, Rosemery Membreno, Jacob L. Houghton
This document contains all supporting materials and methods as well as supplemental figures and tables.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b48d12bb04fcc036f3c5083d0127ce7
https://doi.org/10.1158/1535-7163.22508922
https://doi.org/10.1158/1535-7163.22508922
Autor:
Jason S. Lewis, Brian M. Zeglis, Wolfgang W. Scholz, Ashwin Ragupathi, Dalya Abdel-Atti, Rosemery Membreno, Komal Mandleywala, Lukas M. Carter, Sophie Poty
Supplementary Data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a676f1ba3bbbe25686757b93be6c072
https://doi.org/10.1158/1078-0432.22474679
https://doi.org/10.1158/1078-0432.22474679
Autor:
Jason S. Lewis, Brian M. Zeglis, Wolfgang W. Scholz, Ashwin Ragupathi, Dalya Abdel-Atti, Rosemery Membreno, Komal Mandleywala, Lukas M. Carter, Sophie Poty
Purpose:Interest in targeted alpha-therapy has surged due to α-particles' high cytotoxicity. However, the widespread clinical use of this approach could be limited by on-/off-target toxicities. Here, we investigated the inverse electron-demand Diels
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41a72af8d3272807e6a03abfe2e8ead5
https://doi.org/10.1158/1078-0432.c.6528869
https://doi.org/10.1158/1078-0432.c.6528869
Autor:
Kathryn M. Tully, Jason S. Lewis, Kimberly Fung, Outi Keinänen, Rosemery Membreno, Brian M. Zeglis, Brendon E. Cook
Publikováno v:
Molecular Pharmaceutics. 16:2259-2263
Pretargeted radioimmunotherapy (PRIT) based on the inverse electron demand Diels–Alder reaction has shown promise in murine models of disease, yet the radiation dosimetry of this approach must be optimized to make it a viable clinical option. To th
Autor:
Sophie Poty, Dalya Abdel-Atti, Wolfgang W. Scholz, Ashwin Ragupathi, Komal Mandleywala, Jason S. Lewis, Brian M. Zeglis, Rosemery Membreno, Lukas M. Carter
Publikováno v:
Clinical Cancer Research. 25:868-880
Purpose: Interest in targeted alpha-therapy has surged due to α-particles' high cytotoxicity. However, the widespread clinical use of this approach could be limited by on-/off-target toxicities. Here, we investigated the inverse electron-demand Diel
Autor:
Rosemery Membreno, Ashwin Ragupathi, Jason S. Lewis, Wolfgang W. Scholz, Brian M. Zeglis, Sophie Poty, J M Glaser
Publikováno v:
Chemical Communications. 54:2599-2602
The inverse electron-demand Diels-Alder reaction between tetrazine (Tz) and trans-cyclooctene (TCO) facilitates the efficient radiosynthesis of 225Ac-labelled radioimmunoconjugates in a two-step method, outperforming conventional approaches based on
Publikováno v:
Journal of Nuclear Medicine. 58:1553-1559
In vivo pretargeting stands as a promising approach to harnessing the exquisite tumor-targeting properties of antibodies for nuclear imaging and therapy while simultaneously skirting their pharmacokinetic limitations. The core premise of pretargeting
Autor:
Rosemery Membreno, Jason S. Lewis
Publikováno v:
Mol Imaging Biol
Autor:
Pat Zanzonico, Kristen M. Cunanan, Wolfgang W. Scholz, Sean Carlin, Brian M. Zeglis, Rosemery Membreno, Jacob L. Houghton, Dalya Abdel-Atti, Jason S. Lewis
Publikováno v:
Molecular Cancer Therapeutics. 16:124-133
The pretargeting system based on the inverse electron demand Diels-Alder reaction (IEDDA) between trans-cyclooctene (TCO) and tetrazine (Tz) combines the favorable pharmacokinetic properties of radiolabeled small molecules with the affinity and speci
Publikováno v:
Journal of Visualized Experiments.
While radioimmunotherapy (RIT) is a promising approach for the treatment of cancer, the long pharmacokinetic half-life of radiolabeled antibodies can result in high radiation doses to healthy tissues. Perhaps not surprisingly, several different strat